Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Gross Profit (2019 - 2025)

Historic Gross Profit for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to $17.7 million.

  • Biodesix's Gross Profit rose 2641.0% to $17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.0 million, marking a year-over-year increase of 2557.84%. This contributed to the annual value of $55.8 million for FY2024, which is 5453.06% up from last year.
  • Per Biodesix's latest filing, its Gross Profit stood at $17.7 million for Q3 2025, which was up 2641.0% from $16.0 million recorded in Q2 2025.
  • Biodesix's Gross Profit's 5-year high stood at $17.7 million during Q3 2025, with a 5-year trough of $3.3 million in Q1 2022.
  • Moreover, its 5-year median value for Gross Profit was $10.3 million (2023), whereas its average is $9.9 million.
  • As far as peak fluctuations go, Biodesix's Gross Profit surged by 20293.03% in 2021, and later tumbled by 6888.62% in 2022.
  • Quarter analysis of 5 years shows Biodesix's Gross Profit stood at $4.7 million in 2021, then soared by 33.19% to $6.3 million in 2022, then skyrocketed by 79.24% to $11.3 million in 2023, then skyrocketed by 42.44% to $16.1 million in 2024, then increased by 9.79% to $17.7 million in 2025.
  • Its last three reported values are $17.7 million in Q3 2025, $16.0 million for Q2 2025, and $14.3 million during Q1 2025.